icon-charity icon-donate-car icon-energy icon-fundraise icon-shop icon-sponsorships


Solving Kids' Cancer co-founder John London shares how he stumbled upon nifurtimox as a treatment option for neurublastoma and brought it to a phase I clinical trial.

related videos

Challenging the Status Quo

Solving Kids' Cancer Begins
Watch >

Related Trials

Nifurtimox Phase 1
Read More >

Nifurtimox Phase 2
Read More >